The influence of comorbidities on achieving an N‐terminal pro‐b‐type natriuretic peptide target: a secondary analysis of the GUIDE‐IT trial

The influence of comorbidities on achieving an N‐terminal pro‐b‐type natriuretic peptide target: a secondary analysis of the GUIDE‐IT trial

Abstract Aims N‐terminal pro‐b‐type natriuretic peptide (NT‐proBNP) values may be influenced by patient factors beyond the severity of illness, including atrial fibrillation (AF), renal dysfunction, or increased body mass index (BMI). We hypothesized that these factors may influence the achievement...

Full description

Bibliographic Details
Main Authors: Justin A. Ezekowitz, Wendimagegn Alemayehu, Sarah Rathwell, Andrew D. Grant, Mona Fiuzat, David J. Whellan, Tariq Ahmad, Kirkwood Adams, Ileana L. Piña, Lawton S. Cooper, James L. Januzzi, Eric S. Leifer, Daniel Mark, Christopher M. O'Connor, G. Michael Felker
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:ESC Heart Failure
Subjects:
Heart failure
Atrial fibrillation
Clinical trial
Obesity
Natriuretic peptides
Online Access:https://doi.org/10.1002/ehf2.13692

Internet

https://doi.org/10.1002/ehf2.13692

Similar Items